What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
The first reported dogs made with targeted CRISPR/Cas9 gene editing were two beagles described by Chinese researchers in 2015. The team edited MSTN, the gene for myostatin, a protein that normally limits skeletal-muscle growth. One puppy developed visibly more muscular thighs, while the other showed mosaic editing and did not display the same early muscle phenotype.
That history needs one important qualification: these were not the first genetically modified dogs of any kind. A fluorescent transgenic dog, Ruppy, had been reported in South Korea in 2009. The 2015 study was instead the first reported targeted CRISPR/Cas9 gene knockout in dogs—a proof of principle aimed primarily at creating canine models of human disease, not at producing stronger pets.
As an Amazon Associate I earn from qualifying purchases.
What happened in 2015?
The study, titled “Generation of gene-target dogs using CRISPR/Cas9 system”, was published online on October 12, 2015, in the Journal of Molecular Cell Biology. It was led by researchers associated with Nanjing University, the Guangzhou Institutes of Biomedicine and Health of the Chinese Academy of Sciences, and the Guangzhou Medical Research Institute.
Recommended Free Tools
The researchers used CRISPR/Cas9 to target the canine MSTN gene in beagle embryos. Their work represented an important technical milestone because editing embryos in dogs is more difficult than editing embryos in several commonly used laboratory species. The team combined zygote microinjection with an auto-embryo-transfer procedure to develop the pregnancies.
#1 Best Overall
- Great extension activities for science and biology
- Correlated to standards
- Comprehensive biology vocabulary study
- Fascinating true-to-life illustrations
Contemporaneous reporting based on the study said the researchers injected the gene editor into 35 beagle embryos. Twenty-seven puppies were born, and two carried edited MSTN alleles. The puppies were identified as Tiangou, a female, and Hercules, a male. The numbers show both sides of the result: CRISPR editing in dogs was feasible, but the yield was low.
Why target myostatin?
Myostatin is a protein that acts as a brake on skeletal-muscle growth. It is produced from the MSTN gene, also known as GDF8. When both copies of the gene are disrupted, the body may produce little or no functional myostatin, potentially allowing greater muscle development.
The researchers designed a single-guide RNA to direct Cas9 to the first exon of the dog MSTN gene. Cas9 then cut the DNA at that location. The cell’s repair process can introduce small insertions or deletions—often called indels—that disrupt the gene’s instructions. In this experiment, the intended outcome was an MSTN loss-of-function mutation.
Free tools Windows power users keep installed
One-click scans. No signup required.
This was not a genetic enhancement in the sense of adding a new muscle-building gene. It was a targeted attempt to disable an existing gene. That distinction matters when interpreting both the biology and the risks.
What did the two edited puppies show?
The two puppies did not respond identically, and their differences illustrate why early embryo editing is not the same as producing a perfectly uniform genetic change.
Tiangou
For puppy number 5, the study reported a one-base insertion in one MSTN allele and an eight-base deletion in the other. The researchers reported loss of detectable myostatin protein in skeletal muscle. At four months, Tiangou had visibly more muscular thighs than an unedited sister.
The paper reported the relevant MSTN mutations in all tested cells from Tiangou. That finding is consistent with a more widespread edit in the sampled tissues, although it does not by itself establish that every cell throughout the dog’s body carried exactly the same change.
Hercules
Puppy number 11 had a four-base deletion affecting both copies of the gene in the reported analysis. The researchers also found evidence that Hercules was mosaic: double mutations were present in most, but not all, of the tested cells.
At four months, contemporaneous reporting said Hercules did not show the same visibly increased-muscle phenotype as Tiangou. This difference is biologically plausible. If an embryo is edited after some cell divisions have already occurred, the resulting animal can contain a mixture of edited and unedited cell lineages. The distribution of those cells—and the precise mutations in them—can affect the visible outcome.
Why beagles?
Beagles are widely used in biomedical research and are considered useful canine models for studying human disease. Dogs share a number of anatomical, physiological, and disease characteristics with people that can make them informative models in some areas of medicine.
That does not mean that every result in a dog will translate directly to humans. It means that, for certain diseases, a dog may reproduce aspects of biology that are not captured as well by smaller laboratory animals. The 2015 researchers proposed targeted canine mutations as a way to study conditions including muscular dystrophy and Parkinson’s disease.
The significance of the work was therefore mainly methodological and biomedical: if researchers could deliberately disrupt a selected dog gene, they could potentially create genetically defined disease models rather than relying only on naturally occurring mutations or less precise methods.
For readers who want broader context rather than an experimental protocol, a book on the science and ethics of gene editing can help explain how CRISPR became both a powerful research tool and a subject of public debate. It should be read as background, not as a guide to editing animals.
Was this the first genetically modified dog?
No. The wording “first genetically modified dog” is too broad.
Rank #3
In 2009, South Korean researchers reported Ruppy, a transgenic dog that expressed a fluorescent protein. That was genetic modification, but it was not the same as the targeted CRISPR/Cas9 knockout reported in the 2015 beagles.
The most accurate descriptions of the 2015 achievement are:
- the first reported CRISPR/Cas9 gene-targeted dogs;
- the first reported targeted CRISPR gene knockout in dogs; or
- the first reported MSTN-knockout beagles.
It is also important not to confuse these beagles with Longlong, a dog later reported in China as the world’s first cloned gene-edited dog. Longlong involved somatic-cell nuclear transfer and a different experimental context; it was not the same event as the 2015 embryo-editing study.
How strong was the evidence?
The paper documented edits at the intended target and reported the absence of detectable myostatin protein in skeletal muscle from the edited puppies. The researchers also screened 16 predicted potential off-target sites using a T7E1 assay.
That screening was useful, but it should not be described as proof that the dogs had no unintended genetic changes anywhere in their genomes. The study examined a limited number of predicted sites with the methods available at the time. It did not amount to comprehensive whole-genome surveillance.
Quick wins for a faster PC:
Scan for outdated or missing drivers - takes under a minuteDriver Scan →Clear out junk files and repair common Windows errorsFree Scan →The main limitations included:
- Low efficiency: only two of 27 born puppies were reported as carrying edited MSTN alleles.
- Mosaicism: Hercules carried a mixture of edited and unedited cells in the tested samples.
- Small sample size: two edited animals cannot establish the full range of possible health or behavioral outcomes.
- Short observation window: the prominent phenotype discussed in coverage was assessed at about four months, not across the dogs’ entire lives.
- Limited off-target testing: testing 16 predicted locations cannot rule out every unintended alteration.
- Canine reproductive challenges: embryo survival, pregnancy establishment, transfer procedures, and editing consistency all complicate this work.
Later reviews of canine genome editing continued to identify embryo survival, mosaicism, and the need for improved editing methods as significant technical challenges. The 2015 report showed that targeted editing could work in dogs; it did not show that the process was routine, risk-free, or ready for ordinary pet breeding.
Were these dogs made to be designer pets?
The available reporting does not support that interpretation. The researchers described the work as a way to develop new disease models, and Liangxue Lai said the group had no plan to breed the extra-muscular dogs as pets.
Rank #4
That purpose does not remove the ethical questions. It changes the relevant questions. The issue was not whether consumers could order a “muscular beagle,” but whether the scientific value of a genetically altered canine model justified the embryo manipulation, surrogate procedures, uncertain long-term effects, and use of dogs in biomedical research.
Responsible coverage should avoid claiming that the 2015 dogs were sick, harmed, or commercially sold unless a specific source establishes those facts. The study supports claims about technical feasibility, the intended biomedical purpose, the observed early phenotype, and experimental limitations. It does not provide a complete lifelong welfare assessment.
What does this mean for pet owners?
For ordinary dog owners, the 2015 report does not create a practical route to gene-edited pets. It was a small laboratory study involving specialized embryo manipulation, reproductive procedures, and substantial uncertainty. It should not be treated as an endorsement of breeding for extreme musculature or as evidence that genetic editing is a safe consumer service.
It also does not mean that a muscular-looking dog is necessarily gene-edited. Body condition, exercise, age, breed traits, nutrition, and health all influence appearance. There is no responsible basis for identifying a pet as one of these research animals from appearance alone.
The broader lesson is more limited and more important: CRISPR can be used to make a defined genetic change in a dog embryo, but obtaining a consistent edit and understanding its consequences are separate challenges. A successful edit at one gene is not the same thing as a safe, predictable animal.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Timeline at a glance
| Year | Development | Why it matters |
|---|---|---|
| 2009 | Ruppy, a fluorescent transgenic dog, was reported in South Korea. | Shows that genetically modified dogs predated the CRISPR beagles. |
| 2015 | Chinese researchers reported two beagles with targeted CRISPR/Cas9 edits to MSTN. | First reported targeted CRISPR gene knockout in dogs. |
| 2017 | Longlong was reported as a cloned gene-edited dog. | A later, different combination of gene editing and cloning—not the original 2015 experiment. |
The accurate takeaway
China’s 2015 study marked the first reported use of targeted CRISPR/Cas9 editing to disrupt a gene in dogs. The researchers edited the muscle-regulating MSTN gene in beagle embryos, obtained two edited puppies from 27 births, and observed a stronger muscle phenotype in one of them.
But the result was an early proof of concept, not the creation of a safe new class of household pet. Earlier genetically modified dogs already existed, one edited puppy was mosaic, the sample was very small, and the off-target analysis was limited. Its lasting importance lies in the possibility of building better canine disease models—and in the difficult scientific and ethical questions that come with altering dogs before birth.
Best Value
Frequently Asked Questions
What gene was edited in the first reported CRISPR dogs?
The researchers targeted MSTN, the gene that encodes myostatin, a negative regulator of skeletal-muscle growth.
How many gene-edited puppies were born in the 2015 study?
The researchers injected 35 beagle embryos, and contemporaneous reporting based on the paper said 27 puppies were born. Two—Tiangou and Hercules—carried edited MSTN alleles.
Were these the first genetically modified dogs?
No. They were the first reported dogs with a targeted CRISPR/Cas9 gene knockout. A fluorescent transgenic dog called Ruppy had been reported in South Korea in 2009.
Outdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchPC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Did the edited dogs become stronger pets?
One puppy, Tiangou, had visibly more muscular thighs than an unedited sister at four months. Hercules, whose cells showed mosaic editing, reportedly did not show the same early phenotype. The study was intended for biomedical research, not pet production.
Does this mean gene-edited dogs are available as pets?
No. The study was a specialized laboratory proof of concept involving embryo manipulation and uncertain risks. It does not establish that gene-edited dogs are safe, predictable, or appropriate for consumer breeding.
The Bottom Line
Bottom line: The 2015 Chinese study reported the first targeted CRISPR/Cas9 gene-edited dogs, not the first genetically modified dogs overall. By disrupting MSTN in beagle embryos, researchers produced two edited puppies—one visibly more muscular at four months and one mosaic puppy without the same phenotype. The achievement mattered chiefly for canine disease-model research, while its low efficiency, mosaicism, limited off-target testing, and animal-welfare implications remain essential parts of the story.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →
Leave a Reply